Trial Profile
Prevention of Depression and Enhancement of Cognitive Recovery Following Traumatic Brain Injury With Duloxetine
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 31 Dec 2014
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Depression
- Focus Therapeutic Use
- 30 Aug 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 23 Oct 2010 New trial record